Central antiemetic effects of AS-8112, a dopamine D2, D3, and 5-HT 3 receptor antagonist, in ferrets

By Yoshikawa T.   Yoshida N.   Oka M.  

European Journal of Pharmacology, Vol. 431, Iss. 3, 2001-11 ,pp. : 361-364

Elsevier

Access to resources Recommend Favorite

Investigation of HTR3C mutations for association with 5HT₃ receptor antagonist anti-emetic efficacy

By Ward Michael B   Kotasek Dusan   McKinnon Ross A  

Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. : 1027-1033

Future Medicine

Access to resources Recommend Favorite

Investigation of the effects of YM-31636, a novel 5-HT 3 receptor agonist, on defecation in normal and constipated ferrets

By Ito H.   Kiso T.   Yuki H.   Naitoh Y.   Miyata K.   Iwaoka K.   Yamaguchi T.  

European Journal of Pharmacology, Vol. 424, Iss. 2, 2001-07 ,pp. : 151-157

Elsevier

Access to resources Recommend Favorite

Effects of CP-99, 994, a tachykinin NK 1 receptor antagonist, on abdominal afferent vagal activity in ferrets: evidence for involvement of NK 1 and 5-HT 3 receptors

By Minami M.   Endo T.   Yokota H.   Ogawa T.   Nemoto M.   Hamaue N.   Hirafuji M.   Yoshioka M.   Nagahisa A.   Andrews P.L.R.  

European Journal of Pharmacology, Vol. 428, Iss. 2, 2001-10 ,pp. : 215-220

Elsevier

Access to resources Recommend Favorite

The corticosterone-enhancing effects of the 5-HT 1A receptor antagonist, (S)-UH301, are not mediated by the 5-HT 1A receptor

By Groenink L.   Van der Gugten J.   Mos J.   Maes R.A.A.   Oliver B.  

European Journal of Pharmacology, Vol. 272, Iss. 2, 1995-01 ,pp. : 177-183

Elsevier

Access to resources Recommend Favorite